HeartBeam ROA 2020-2024 | BEAT
Current and historical return on assets (ROA) values for HeartBeam (BEAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| HeartBeam ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-12-31 | $-0.02B | $0.00B | -235.29% |
| 2024-09-30 | $-0.02B | $0.01B | -158.33% |
| 2024-06-30 | $-0.02B | $0.01B | -111.48% |
| 2024-03-31 | $-0.02B | $0.01B | -82.19% |
| 2023-12-31 | $-0.01B | $0.02B | -93.33% |
| 2023-09-30 | $-0.01B | $0.02B | -119.15% |
| 2023-06-30 | $-0.02B | $0.02B | -176.47% |
| 2023-03-31 | $-0.02B | $0.00B | -290.91% |
| 2022-12-31 | $-0.01B | $0.00B | -164.71% |
| 2022-09-30 | $-0.01B | $0.01B | -109.09% |
| 2022-06-30 | $-0.01B | $0.01B | -94.74% |
| 2022-03-31 | $-0.01B | $0.01B | -85.71% |
| 2021-12-31 | $0.00B | $0.01B | -106.67% |
| 2021-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.061B | $0.000B |
| HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.687B | 52.05 |
| Tempus AI (TEM) | United States | $9.349B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
| Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
| IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
| Privia Health (PRVA) | United States | $2.840B | 212.82 |
| Enovis (ENOV) | United States | $1.994B | 12.34 |
| Schrodinger (SDGR) | United States | $1.883B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.471B | 31.72 |
| Phreesia (PHR) | United States | $1.461B | 0.00 |
| Azenta (AZTA) | United States | $1.216B | 56.62 |
| 10x Genomics (TXG) | United States | $1.025B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
| Talkspace (TALK) | United States | $0.532B | 316.00 |
| Veradigm (MDRX) | United States | $0.457B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.389B | 0.00 |
| Claritev (CTEV) | United States | $0.373B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Pulmonx (LUNG) | United States | $0.212B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
| CareCloud (CCLD) | United States | $0.077B | 3.31 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | China | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |